Stock Market Reviews

HRMY (Harmony Biosciences Holdings, Inc.) News

Get the latest news, insights, and market updates on HRMY (Harmony Biosciences Holdings, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• HRMY vs. ARGX: Which Stock Is the Better Value Option?
  HRMY vs. ARGX: Which Stock Is the Better Value Option?
  Feb 11, 2026 - $HRMY
• Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
  Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
  Feb 11, 2026 - $HRMY
• Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
  PLYMOUTH MEETING, Pa., February 10, 2026--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on February 24, 2026, at 8:30 a.m. ET to discuss the results.
  Feb 10, 2026 - $HRMY
• 5 Value Picks Amid AI-Driven Tech Sell-Off & U.S.-Iran Tensions
  AI fears and U.S.-Iran tensions rattle markets. Value investors should consider buying stocks like HRMY, AGRO, SQM, ANGI and PHIN.
  Feb 4, 2026 - $HRMY
• Zacks.com featured highlights include Harmony Biosciences, Universal Health Services, Concentrix and Global Payments
  Harmony Biosciences stands out among value stocks as tech volatility grows, with strong cash flow, solid earnings surprises and growth forecasts.
  Feb 2, 2026 - $HRMY
• CFO’s Full Share Exit Contrasts With Harmony’s Positive WAKIX Growth Story
  Harmony Biosciences Holdings (NasdaqGM:HRMY) Chief Financial Officer Sandip Kapadia recently sold multiple blocks of company shares. These transactions included a full exit from his direct equity ownership, carried out under a pre arranged trading plan. The sales come at a time when the company has reported strong financials and issued optimistic guidance. Harmony Biosciences focuses on therapies for rare neurological conditions, a space that continues to attract attention as treatments and...
  Feb 2, 2026 - $HRMY
• Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity
  This top executive at Harmony Biosciences previous sold all of his direct shares in the company in early January 2026. But towards the end of the month, some options and restricted stock units vested, and everything changed.
  Feb 1, 2026 - $HRMY
• Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800
  This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership in mid-January 2026.
  Feb 1, 2026 - $HRMY
• Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800
  This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.
  Feb 1, 2026 - $HRMY
• Is Harmony Biosciences (HRMY) a Solid Growth Stock? 3 Reasons to Think "Yes"
  Harmony Biosciences (HRMY) could produce exceptional returns because of its solid growth attributes.
  Jan 29, 2026 - $HRMY